Apolipoprotein A-II, HDL metabolism and atherosclerosis (Q34740994)

4 August 2017

1 reference

title

Apolipoprotein A-II, HDL metabolism and atherosclerosis (English)

1 reference

4 August 2017

1 reference

Jean-Charles Fruchart

3

0 references

Anne Tailleux

object named as

Anne Tailleux

1

0 references

author name string

Patrick Duriez

2

1 reference

4 August 2017

Véronique Clavey

4

1 reference

4 August 2017

publication date

1 September 2002

1 reference

4 August 2017

1 reference

4 August 2017

volume

164

1 reference

4 August 2017

issue

1

1 reference

4 August 2017

page(s)

1-13

1 reference

Isolation and characterization of apolipoproteins A-I, A-II, and A-IV

4 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900751-1

Amino acid sequence of human apoLp-Gln-II (apoA-II), an apolipoprotein isolated from the high-density lipoprotein complex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900751-1

The human apolipoprotein A-II gene is located on chromosome 1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900751-1

Fibrates increase human apolipoprotein A-II expression through activation of the peroxisome proliferator-activated receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900751-1

Retinoids increase human apolipoprotein A-11 expression through activation of the retinoid X receptor but not the retinoic acid receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900751-1

DNA binding specificity and transactivation properties of SREBP-2 bound to multiple sites on the human apoA-II promoter

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900751-1

Plasma-high-density-lipoprotein concentration and development of ischaemic heart-disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900751-1

Associations of high-density lipoprotein subclasses and apolipoproteins with ischemic heart disease and coronary atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900751-1

Plasma high density lipoproteins. Metabolism and relationship to atherogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900751-1

Epidemiologic aspects of lipid abnormalities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900751-1

Multivariate analyses of serum apolipoproteins and risk factors in relation to acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900751-1

Quantitative determination of human plasma apolipoprotein A-II by a non competitive enzyme-linked immunosorbent assay

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900751-1

High-density lipoprotein subclasses and apolipoprotein A-I.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900751-1

Characterization of two HDL subfractions and LpA-I, LpA-I:A-II distribution profiles and clinical characteristics of hyperalphalipoproteinemic subjects without cholesterol ester transfer protein deficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900751-1

Familial deficiency of apolipoproteins A-I and C-III and precocious coronary-artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900751-1

Apolipoprotein A-I Q[-2]X causing isolated apolipoprotein A-I deficiency in a family with analphalipoproteinemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900751-1

Elevated high density lipoprotein cholesterol levels correlate with decreased apolipoprotein A-I and A-II fractional catabolic rate in women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900751-1

Stable isotope turnover of apolipoproteins of high-density lipoproteins in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900751-1

Human HDL cholesterol levels are determined by apoA-I fractional catabolic rate, which correlates inversely with estimates of HDL particle size. Effects of gender, hepatic and lipoprotein lipases, triglyceride and insulin levels, and body fat distri

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900751-1

Markedly accelerated catabolism of apolipoprotein A-II (ApoA-II) and high density lipoproteins containing ApoA-II in classic lecithin: cholesterol acyltransferase deficiency and fish-eye disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900751-1

Apolipoprotein A-II production rate is a major factor regulating the distribution of apolipoprotein A-I among HDL subclasses LpA-I and LpA-I:A-II in normolipidemic humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900751-1

In vivo metabolism of apo A-I and apo A-II in subjects with apo A-I(Lys107-->0) associated with reduced HDL cholesterol and Lp(AI w AII) deficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900751-1

High density lipoprotein and coronary heart disease: insights from mutations leading to low high density lipoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900751-1

High density lipoproteins and arteriosclerosis. Role of cholesterol efflux and reverse cholesterol transport

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900751-1

Remodelling of high density lipoproteins by plasma factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900751-1

Purification of an apolipoprotein A binding protein from mouse adipose cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900751-1

Modulation of cholesterol efflux from Fu5AH hepatoma cells by the apolipoprotein content of high density lipoprotein particles. Particles containing various proportions of apolipoproteins A-I and A-II

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900751-1

Cholesterol efflux from cultured adipose cells is mediated by LpAI particles but not by LpAI:AII particles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900751-1

Cholesterol efflux from macrophages mediated by high-density lipoprotein subfractions, which differ principally in apolipoprotein A-I and apolipoprotein A-II ratios

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900751-1

Effects of interactions of apolipoprotein A-II with apolipoproteins A-I or A-IV on [3H]cholesterol efflux and uptake in cell culture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900751-1

Cholesterol efflux from adipose cells is coupled to diacylglycerol production and protein kinase C activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900751-1

Differential role of apolipoprotein AI-containing particles in cholesterol efflux from adipose cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900751-1

The molecular structure of apolipoprotein A-II modulates the capacity of HDL to promote cell cholesterol efflux

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900751-1

Comparison of the structural and functional effects of monomeric and dimeric human apolipoprotein A-II in high density lipoprotein particles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900751-1

Effect of the human plasma apolipoproteins and phosphatidylcholine acyl donor on the activity of lecithin. Cholesterol acyltransferase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900751-1

Activation of the enzymic activity of hepatic lipase by apolipoprotein A-II. Characterization of a major component of high density lipoprotein as the activating plasma component in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900751-1

Apolipoprotein A-II influences the substrate properties of human HDL2 and HDL3 for hepatic lipase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900751-1

Human ApoA-II inhibits the hydrolysis of HDL triglyceride and the decrease of HDL size induced by hypertriglyceridemia and cholesteryl ester transfer protein in transgenic mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900751-1

The effect of apolipoprotein A-II on the structure and function of apolipoprotein A-I in a homogeneous reconstituted high density lipoprotein particle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900751-1

Displacement of apo A-I from HDL by apo A-II or its C-terminal helix promotes the formation of pre-beta1 migrating particles and decreases LCAT activation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900751-1

The influence of apolipoproteins on the hepatic lipase-mediated hydrolysis of high density lipoprotein phospholipid and triacylglycerol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900751-1

Selective uptake of cholesteryl esters from high-density lipoprotein-derived LpA-I and LpA-I:A-II particles by hepatic cells in culture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900751-1

Cholesterol Efflux, Cholesterol Esterification, and Cholesteryl Ester Transfer by LpA-I and LpA-I/A-II in Native Plasma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900751-1

Apolipoprotein AII enrichment of HDL enhances their affinity for class B type I scavenger receptor but inhibits specific cholesteryl ester uptake

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900751-1

Apolipoprotein A-II modulates the binding and selective lipid uptake of reconstituted high density lipoprotein by scavenger receptor BI.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900751-1

Displacement of the human apoprotein A-I by the human apoprotein A-II from complexes of (apoprotein A-I)-phosphatidylcholine-cholesterol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900751-1

Atherosclerosis in transgenic mice overexpressing apolipoprotein A-II.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900751-1

Overexpression of apolipoprotein AII in transgenic mice converts high density lipoproteins to proinflammatory particles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900751-1

Dramatically decreased high density lipoprotein cholesterol, increased remnant clearance, and insulin hypersensitivity in apolipoprotein A-II knockout mice suggest a complex role for apolipoprotein A-II in atherosclerosis susceptibility

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900751-1

Protein composition determines the anti-atherogenic properties of HDL in transgenic mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900751-1

Functional lecithin:cholesterol acyltransferase deficiency and high density lipoprotein deficiency in transgenic mice overexpressing human apolipoprotein A-II

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900751-1

Overexpression of human apolipoprotein A-II in mice induces hypertriglyceridemia due to defective very low density lipoprotein hydrolysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900751-1

Decreased Susceptibility to Diet-Induced Atherosclerosis in Human Apolipoprotein A-II Transgenic Mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900751-1

A 700-bp fragment of the human antithrombin III promoter is sufficient to confer high, tissue-specific expression on human apolipoprotein A-II in transgenic mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900751-1

Free cholesterol deposition in the cornea of human apolipoprotein A-II transgenic mice with functional lecithin: cholesterol acyltransferase deficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900751-1

Expression of human apolipoprotein A-I in transgenic mice results in reduced plasma levels of murine apolipoprotein A-I and the appearance of two new high density lipoprotein size subclasses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900751-1

Expression of human lecithin-cholesterol acyltransferase in transgenic mice. Effect of human apolipoprotein AI and human apolipoprotein all on plasma lipoprotein cholesterol metabolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900751-1

Cholesterol Efflux, Lecithin−Cholesterol Acyltransferase Activity, and Pre-β Particle Formation by Serum from Human Apolipoprotein A-I and Apolipoprotein A-I/Apolipoprotein A-II Transgenic Mice Consistent with the Latter Being Less Effective for R

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900751-1

Increased production of very-low-density lipoproteins in transgenic mice overexpressing human apolipoprotein A-II and fed with a high-fat diet

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900751-1

10.1016/S0021-9150(01)00751-1

7 January 2021

Identifiers

DOI

1 reference

4 August 2017

1 reference